Modeling Stress-precipitated Vaping Behavior
1 other identifier
interventional
51
1 country
1
Brief Summary
The primary aims of this pilot study were to (1) initially validate the applicability of a human laboratory model of relapse initially developed for smokers to e-cigarette users; (2) to use this human laboratory model of lapse behavior to examine the effects of acute psychological stress on vaping-lapse behavior among adults who are experienced, e-cigarette users.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedFirst Submitted
Initial submission to the registry
August 13, 2020
CompletedFirst Posted
Study publicly available on registry
August 21, 2020
CompletedAugust 21, 2020
August 1, 2020
8 months
August 13, 2020
August 19, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
latency to initiate ad-lib vaping session (in minutes)
Time to vaping during the vaping delay task. Range of time delay is 0 minutes to 50 minutes.
During the two laboratory sessions which occur within 1 week after screening/baseline.
number of puffs purchased and consumed during the self-administration period
Number of e-cigarette uses purchased during the self-administration phase of the vaping delay task. Range of puffs is 0 to 20.
During the two laboratory sessions which occur within 1 week after screening/baseline
Secondary Outcomes (2)
Craving
The VAS will be collected at each laboratory session (within 1 week after screening/baseline) 5 times: baseline (pre task), post task (+15 minutes), decision to smoke (+20 minutes), +30 minutes smoking ab-lib, and +60 minutes during smoking ab-lib
Stress
The VAS will be collected at each laboratory session (within 1 week after screening/baseline) 5 times: baseline (pre task), post task (+15 minutes), decision to smoke (+20 minutes), +30 minutes smoking ab-lib, and +60 minutes during smoking ab-lib
Study Arms (2)
Control task-
SHAM COMPARATORThe Control Task was implemented to ensure the specificity of the psychological stress effects had on study outcomes. Therefore, the Control Task had a similar procedure and the same duration of the TSST, lacking except for only the psychologically stressful component. The control task consisted of (a) Participants had a 5-min a preparation section and anticipation phase (5 min ), (b) a reading task where they had to. Then, all participants had to be read a simple text in a low voice (5 min), and (c) an arithmetic section where they were asked to perform an easy mathematical calculation (5 mins).
Experimental Task- Trier Social Stress Task
EXPERIMENTALThe Trier Social Stress Task (TSST) is a standardized, 15-minute laboratory task designed to induce psychological stress in laboratory settings (Kirschbaum, Pirke, \& Hellhammer, 1993). The TSST consists of three continuously successive phases: (a) an anticipation period (5 min); (b) a free speech task (5 min); and (c) a mental arithmetic task (5 min). As is standard in the TSST procedure, participants were told by a research staff member that they would provide a brief speech about "their dream job" in front of a critical audience. At the end of the speech, a member of the audience instructed the participant to conduct serial subtractions as accurately and quickly as possible.
Interventions
Same as Arm
Eligibility Criteria
You may qualify if:
- at least 18 years old
- e-cigarette users
- using ≥1 mL of e-cigarette liquid per day with a nicotine concentration of ≥3mg/ml
- had used an e-cigarette for at least three months
You may not qualify if:
- Current smokers
- Psychiatric or medical condition based
- Using a prescription medication other than birth control
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clemson Universitylead
- University of Vermontcollaborator
Study Sites (1)
University of Vermont
Burlington, Vermont, 05405, United States
Related Publications (2)
Pericot-Valverde I, Yoon JH, Byrne KA, Heo M, Niu J, Litwin AH, Gaalema DE. Effects of short-term nicotine deprivation on delay discounting among young, experienced, exclusive ENDS users: An initial study. Exp Clin Psychopharmacol. 2023 Jun;31(3):724-732. doi: 10.1037/pha0000612. Epub 2022 Nov 10.
PMID: 36355684DERIVEDPericot-Valverde I, Heo M, Litwin AH, Niu J, Gaalema DE. Modeling the effect of stress on vaping behavior among young adults: A randomized cross-over pilot study. Drug Alcohol Depend. 2021 Aug 1;225:108798. doi: 10.1016/j.drugalcdep.2021.108798. Epub 2021 May 30.
PMID: 34091155DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
August 13, 2020
First Posted
August 21, 2020
Study Start
October 25, 2017
Primary Completion
June 30, 2018
Study Completion
June 30, 2018
Last Updated
August 21, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share